113 related articles for article (PubMed ID: 16436673)
1. CSR1 suppresses tumor growth and metastasis of prostate cancer.
Yu G; Tseng GC; Yu YP; Gavel T; Nelson J; Wells A; Michalopoulos G; Kokkinakis D; Luo JH
Am J Pathol; 2006 Feb; 168(2):597-607. PubMed ID: 16436673
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression.
Zuo ZH; Yu YP; Ding Y; Liu S; Martin A; Tseng G; Luo JH
Am J Pathol; 2015 Jul; 185(7):1991-9. PubMed ID: 25956032
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.
Luo HR; Liu Y; Wan XD; Li JL; Wu M; Zhang QM; Wu DL; Zhao X; Wang TR
Cell Physiol Biochem; 2018; 46(5):1861-1867. PubMed ID: 29705808
[TBL] [Abstract][Full Text] [Related]
4. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.
Yu YP; Yu G; Tseng G; Cieply K; Nelson J; Defrances M; Zarnegar R; Michalopoulos G; Luo JH
Cancer Res; 2007 Sep; 67(17):8043-50. PubMed ID: 17804715
[TBL] [Abstract][Full Text] [Related]
5. Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
Ren B; Yu YP; Tseng GC; Wu C; Chen K; Rao UN; Nelson J; Michalopoulos GK; Luo JH
J Natl Cancer Inst; 2007 Jun; 99(11):868-80. PubMed ID: 17551147
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
[TBL] [Abstract][Full Text] [Related]
7. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
8. CSR1 induces cell death through inactivation of CPSF3.
Zhu ZH; Yu YP; Shi YK; Nelson JB; Luo JH
Oncogene; 2009 Jan; 28(1):41-51. PubMed ID: 18806823
[TBL] [Abstract][Full Text] [Related]
9. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
10. Cellular stress response 1 down-regulates the expression of epidermal growth factor receptor and platelet-derived growth factor receptor through inactivation of splicing factor 3A3.
Zuo ZH; Yu YP; Martin A; Luo JH
Mol Carcinog; 2017 Feb; 56(2):315-324. PubMed ID: 27148859
[TBL] [Abstract][Full Text] [Related]
11. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
12. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
13. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
14. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
[TBL] [Abstract][Full Text] [Related]
15. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M
Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CSR1 with XIAP reverses inhibition of caspases and accelerates cell death.
Zheng ZL; Tan LZ; Yu YP; Michalopoulos G; Luo JH
Am J Pathol; 2012 Aug; 181(2):463-71. PubMed ID: 22683311
[TBL] [Abstract][Full Text] [Related]
20. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
